StockData
Lucid Diagnostics Inc. logo

Lucid Diagnostics Inc. (LUCD) stock

LUCDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3034% above fair value
$0.40+0.00 (+0.30%)

Close on Nov 17, 2026Market cap $81.09MP/E –Yield –

Lucid Diagnostics gross margin

Gross margin is gross profit as a percentage of revenue.

Lucid Diagnostics's gross margin for the twelve months ending Dec 31, 2022 was 100.0%. For fiscal 2025 it was -41.7%, against -63.3% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-41.7%+21.6
FY2024Dec 31, 2024-63.3%−163.3
FY2022Dec 31, 2022100.0%+0.0
FY2021Dec 31, 2021100.0%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 20262.0%−98.0
Q1 FY2026Mar 31, 2026-29.4%−129.4
Q2 FY2025Jun 30, 2025-34.4%+60.8
Q1 FY2025Mar 31, 2025-87.3%−187.3
Q4 FY2022Dec 31, 2022100.0%+0.0
Q3 FY2022Sep 30, 2022100.0%–
Q1 FY2022Mar 31, 2022-95.2%–
Q4 FY2021Dec 31, 2021100.0%–
Q3 FY2021Sep 30, 2021100.0%–

More Lucid Diagnostics figures

See a number that looks wrong?